APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxychloroquine Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hydroxychloroquine Drug Industry Growth and Trends Forecast to 2032

2 January 2026109 pages

Choose your research edition.

Industry ResearchHydroxychloroquine Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxychloroquine Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Hydroxychloroquine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxychloroquine Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxychloroquine Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Hydroxychloroquine Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hydroxychloroquine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hydroxychloroquine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydroxychloroquine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hydroxychloroquine Drug include Teva Pharmaceutical, Sanofi, Novartis, Mylan, Zydus Cadila, Sun Pharmaceutical, Prasco Laboratories, Lupin Limited and Dr. Reddy’s Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hydroxychloroquine Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hydroxychloroquine Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hydroxychloroquine Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hydroxychloroquine Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hydroxychloroquine Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hydroxychloroquine Drug Market by Company

Teva Pharmaceutical

Sanofi

Novartis

Mylan

Zydus Cadila

Sun Pharmaceutical

Prasco Laboratories

Lupin Limited

Dr. Reddy’s Laboratories

Amneal Pharmaceuticals

Hydroxychloroquine Drug Segment by Type

COVID-19

Systemic Lupus Erythematosus

Malaria

Rheumatoid Arthritis

Others

Hydroxychloroquine Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Hydroxychloroquine Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxychloroquine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxychloroquine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxychloroquine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxychloroquine Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hydroxychloroquine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of COVID-19 Table 2. Major Company of Systemic Lupus Erythematosus Table 3. Major Company of Malaria Table 4. Major Company of Rheumatoid Arthritis Table 5. Major Company of Others Table 6. Global Hydroxychloroquine Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Hydroxychloroquine Drug Sales by Type (2021-2026) & (K Units) Table 8. Global Hydroxychloroquine Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Hydroxychloroquine Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Hydroxychloroquine Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Hydroxychloroquine Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Hydroxychloroquine Drug Sales by Type (2027-2032) & (K Units) Table 13. Global Hydroxychloroquine Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Hydroxychloroquine Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Hydroxychloroquine Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Hydroxychloroquine Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Hydroxychloroquine Drug Sales by Type (2021-2026) & (K Units) Table 18. North America Hydroxychloroquine Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Hydroxychloroquine Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe Hydroxychloroquine Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Hydroxychloroquine Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Hydroxychloroquine Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Hydroxychloroquine Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America Hydroxychloroquine Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Hydroxychloroquine Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Hydroxychloroquine Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Hydroxychloroquine Drug Industry Trends Table 28. Hydroxychloroquine Drug Industry Drivers Table 29. Hydroxychloroquine Drug Industry Opportunities and Challenges Table 30. Hydroxychloroquine Drug Industry Restraints Table 31. Global Hydroxychloroquine Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Hydroxychloroquine Drug Revenue Market Share by Company (2021-2026) Table 33. Global Hydroxychloroquine Drug Sales by Company (2021-2026) & (K Units) Table 34. Global Hydroxychloroquine Drug Sales Share by Company (2021-2026) Table 35. Global Hydroxychloroquine Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Hydroxychloroquine Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Hydroxychloroquine Drug Major Company Production Sites and Headquarters Table 38. Global Hydroxychloroquine Drug Company, Product Type & Application Table 39. Global Hydroxychloroquine Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Hydroxychloroquine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Hydroxychloroquine Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Hydroxychloroquine Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Hydroxychloroquine Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Hydroxychloroquine Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Hydroxychloroquine Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Hydroxychloroquine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Hydroxychloroquine Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Hydroxychloroquine Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Hydroxychloroquine Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Hydroxychloroquine Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Hydroxychloroquine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Hydroxychloroquine Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Hydroxychloroquine Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Hydroxychloroquine Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Hydroxychloroquine Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Hydroxychloroquine Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Hydroxychloroquine Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Hydroxychloroquine Drug Sales by Application (2027-2032) & (K Units) Table 60. Global Hydroxychloroquine Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Hydroxychloroquine Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Hydroxychloroquine Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Hydroxychloroquine Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Hydroxychloroquine Drug Sales by Application (2021-2026) & (K Units) Table 65. North America Hydroxychloroquine Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Hydroxychloroquine Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe Hydroxychloroquine Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Hydroxychloroquine Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Hydroxychloroquine Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Hydroxychloroquine Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America Hydroxychloroquine Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Hydroxychloroquine Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Hydroxychloroquine Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Teva Pharmaceutical Company Information Table 75. Teva Pharmaceutical Business Overview Table 76. Teva Pharmaceutical Hydroxychloroquine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Teva Pharmaceutical Hydroxychloroquine Drug Product Portfolio Table 78. Teva Pharmaceutical Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Hydroxychloroquine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sanofi Hydroxychloroquine Drug Product Portfolio Table 83. Sanofi Recent Development Table 84. Novartis Company Information Table 85. Novartis Business Overview Table 86. Novartis Hydroxychloroquine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Novartis Hydroxychloroquine Drug Product Portfolio Table 88. Novartis Recent Development Table 89. Mylan Company Information Table 90. Mylan Business Overview Table 91. Mylan Hydroxychloroquine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Mylan Hydroxychloroquine Drug Product Portfolio Table 93. Mylan Recent Development Table 94. Zydus Cadila Company Information Table 95. Zydus Cadila Business Overview Table 96. Zydus Cadila Hydroxychloroquine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Zydus Cadila Hydroxychloroquine Drug Product Portfolio Table 98. Zydus Cadila Recent Development Table 99. Sun Pharmaceutical Company Information Table 100. Sun Pharmaceutical Business Overview Table 101. Sun Pharmaceutical Hydroxychloroquine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Sun Pharmaceutical Hydroxychloroquine Drug Product Portfolio Table 103. Sun Pharmaceutical Recent Development Table 104. Prasco Laboratories Company Information Table 105. Prasco Laboratories Business Overview Table 106. Prasco Laboratories Hydroxychloroquine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Prasco Laboratories Hydroxychloroquine Drug Product Portfolio Table 108. Prasco Laboratories Recent Development Table 109. Lupin Limited Company Information Table 110. Lupin Limited Business Overview Table 111. Lupin Limited Hydroxychloroquine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Lupin Limited Hydroxychloroquine Drug Product Portfolio Table 113. Lupin Limited Recent Development Table 114. Dr. Reddy’s Laboratories Company Information Table 115. Dr. Reddy’s Laboratories Business Overview Table 116. Dr. Reddy’s Laboratories Hydroxychloroquine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Dr. Reddy’s Laboratories Hydroxychloroquine Drug Product Portfolio Table 118. Dr. Reddy’s Laboratories Recent Development Table 119. Amneal Pharmaceuticals Company Information Table 120. Amneal Pharmaceuticals Business Overview Table 121. Amneal Pharmaceuticals Hydroxychloroquine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Amneal Pharmaceuticals Hydroxychloroquine Drug Product Portfolio Table 123. Amneal Pharmaceuticals Recent Development Table 124. North America Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. North America Hydroxychloroquine Drug Sales by Country (2021-2026) & (K Units) Table 126. North America Hydroxychloroquine Drug Sales Market Share by Country (2021-2026) Table 127. North America Hydroxychloroquine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 128. North America Hydroxychloroquine Drug Sales Market Share Forecast by Country (2027-2032) Table 129. North America Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America Hydroxychloroquine Drug Market Size by Country (2021-2026) & (US$ Million) Table 131. North America Hydroxychloroquine Drug Market Share by Country (2021-2026) Table 132. North America Hydroxychloroquine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America Hydroxychloroquine Drug Market Share Forecast by Country (2027-2032) Table 134. Europe Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Europe Hydroxychloroquine Drug Sales by Country (2021-2026) & (K Units) Table 136. Europe Hydroxychloroquine Drug Sales Market Share by Country (2021-2026) Table 137. Europe Hydroxychloroquine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 138. Europe Hydroxychloroquine Drug Sales Market Share Forecast by Country (2027-2032) Table 139. Europe Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe Hydroxychloroquine Drug Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe Hydroxychloroquine Drug Market Share by Country (2021-2026) Table 142. Europe Hydroxychloroquine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe Hydroxychloroquine Drug Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Hydroxychloroquine Drug Sales by Country (2021-2026) & (K Units) Table 146. Asia-Pacific Hydroxychloroquine Drug Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific Hydroxychloroquine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 148. Asia-Pacific Hydroxychloroquine Drug Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Hydroxychloroquine Drug Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific Hydroxychloroquine Drug Market Share by Country (2021-2026) Table 152. Asia-Pacific Hydroxychloroquine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific Hydroxychloroquine Drug Market Share Forecast by Country (2027-2032) Table 154. Latin America Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Latin America Hydroxychloroquine Drug Sales by Country (2021-2026) & (K Units) Table 156. Latin America Hydroxychloroquine Drug Sales Market Share by Country (2021-2026) Table 157. Latin America Hydroxychloroquine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 158. Latin America Hydroxychloroquine Drug Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America Hydroxychloroquine Drug Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America Hydroxychloroquine Drug Market Share by Country (2021-2026) Table 162. Latin America Hydroxychloroquine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America Hydroxychloroquine Drug Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Hydroxychloroquine Drug Sales by Country (2021-2026) & (K Units) Table 166. Middle East and Africa Hydroxychloroquine Drug Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa Hydroxychloroquine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 168. Middle East and Africa Hydroxychloroquine Drug Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Hydroxychloroquine Drug Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Hydroxychloroquine Drug Market Share by Country (2021-2026) Table 172. Middle East and Africa Hydroxychloroquine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa Hydroxychloroquine Drug Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Hydroxychloroquine Drug Distributors List Table 177. Hydroxychloroquine Drug Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Hydroxychloroquine Drug Image Figure 2. Global Hydroxychloroquine Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxychloroquine Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxychloroquine Drug Sales (2021-2032) & (K Units) Figure 5. COVID-19 Image Figure 6. Global COVID-19 Sales YoY Growth (2021-2032) & (K Units) Figure 7. Systemic Lupus Erythematosus Image Figure 8. Global Systemic Lupus Erythematosus Sales YoY Growth (2021-2032) & (K Units) Figure 9. Malaria Image Figure 10. Global Malaria Sales YoY Growth (2021-2032) & (K Units) Figure 11. Rheumatoid Arthritis Image Figure 12. Global Rheumatoid Arthritis Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Hydroxychloroquine Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Hydroxychloroquine Drug Market Share by Type 2025 VS 2032 Figure 17. North America Hydroxychloroquine Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Hydroxychloroquine Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Hydroxychloroquine Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Hydroxychloroquine Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Hydroxychloroquine Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Hydroxychloroquine Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Hydroxychloroquine Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Hydroxychloroquine Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Hydroxychloroquine Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Hydroxychloroquine Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Hydroxychloroquine Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Hospital Pharmacies Image Figure 34. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Hydroxychloroquine Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Hydroxychloroquine Drug Market Share by Application 2025 VS 2032 Figure 37. North America Hydroxychloroquine Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Hydroxychloroquine Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Hydroxychloroquine Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Hydroxychloroquine Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Hydroxychloroquine Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Hydroxychloroquine Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Hydroxychloroquine Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Hydroxychloroquine Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Hydroxychloroquine Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Hydroxychloroquine Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Hydroxychloroquine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Hydroxychloroquine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Hydroxychloroquine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Hydroxychloroquine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Hydroxychloroquine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Hydroxychloroquine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Hydroxychloroquine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Hydroxychloroquine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Hydroxychloroquine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Hydroxychloroquine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Hydroxychloroquine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Hydroxychloroquine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Hydroxychloroquine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Hydroxychloroquine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Hydroxychloroquine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Hydroxychloroquine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Hydroxychloroquine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Hydroxychloroquine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Hydroxychloroquine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Hydroxychloroquine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Hydroxychloroquine Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Hydroxychloroquine Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • COVID-19
  • Systemic Lupus Erythematosus
  • Malaria
  • Rheumatoid Arthritis
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Novartis
  • Mylan
  • Zydus Cadila
  • Sun Pharmaceutical
  • Prasco Laboratories
  • Lupin Limited
  • Dr. Reddy’s Laboratories
  • Amneal Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hydroxychloroquine Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hydroxychloroquine Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hydroxychloroquine Drug Market by Type
  6. 1.3.1 COVID-19
  7. 1.3.2 Systemic Lupus Erythematosus
  8. 1.3.3 Malaria
  9. 1.3.4 Rheumatoid Arthritis
  10. 1.3.5 Others
  11. 1.4 Global Hydroxychloroquine Drug Market Size by Type
  12. 1.4.1 Global Hydroxychloroquine Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Hydroxychloroquine Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Hydroxychloroquine Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Hydroxychloroquine Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Hydroxychloroquine Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Hydroxychloroquine Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Hydroxychloroquine Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Hydroxychloroquine Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hydroxychloroquine Drug Industry Trends
  2. 2.2 Hydroxychloroquine Drug Industry Drivers
  3. 2.3 Hydroxychloroquine Drug Industry Opportunities and Challenges
  4. 2.4 Hydroxychloroquine Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hydroxychloroquine Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Hydroxychloroquine Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Hydroxychloroquine Drug Price (2021-2026)
  4. 3.4 Global Hydroxychloroquine Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxychloroquine Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Hydroxychloroquine Drug Company, Product Type & Application
  7. 3.7 Global Hydroxychloroquine Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxychloroquine Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxychloroquine Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxychloroquine Drug Tier 1, Tier 2, and Tier 3
4 Hydroxychloroquine Drug Regional Status and Outlook
  1. 4.1 Global Hydroxychloroquine Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hydroxychloroquine Drug Historic Market Size by Region
  3. 4.2.1 Global Hydroxychloroquine Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hydroxychloroquine Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hydroxychloroquine Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hydroxychloroquine Drug Forecasted Market Size by Region
  7. 4.3.1 Global Hydroxychloroquine Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hydroxychloroquine Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hydroxychloroquine Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hydroxychloroquine Drug by Application
  1. 5.1 Hydroxychloroquine Drug Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Hydroxychloroquine Drug Market Size by Application
  6. 5.2.1 Global Hydroxychloroquine Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Hydroxychloroquine Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Hydroxychloroquine Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Hydroxychloroquine Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Hydroxychloroquine Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Hydroxychloroquine Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Hydroxychloroquine Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Hydroxychloroquine Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Hydroxychloroquine Drug Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Hydroxychloroquine Drug Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Hydroxychloroquine Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Hydroxychloroquine Drug Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Zydus Cadila
  26. 6.5.1 Zydus Cadila Company Information
  27. 6.5.2 Zydus Cadila Business Overview
  28. 6.5.3 Zydus Cadila Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zydus Cadila Hydroxychloroquine Drug Product Portfolio
  30. 6.5.5 Zydus Cadila Recent Developments
  31. 6.6 Sun Pharmaceutical
  32. 6.6.1 Sun Pharmaceutical Company Information
  33. 6.6.2 Sun Pharmaceutical Business Overview
  34. 6.6.3 Sun Pharmaceutical Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sun Pharmaceutical Hydroxychloroquine Drug Product Portfolio
  36. 6.6.5 Sun Pharmaceutical Recent Developments
  37. 6.7 Prasco Laboratories
  38. 6.7.1 Prasco Laboratories Company Information
  39. 6.7.2 Prasco Laboratories Business Overview
  40. 6.7.3 Prasco Laboratories Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Prasco Laboratories Hydroxychloroquine Drug Product Portfolio
  42. 6.7.5 Prasco Laboratories Recent Developments
  43. 6.8 Lupin Limited
  44. 6.8.1 Lupin Limited Company Information
  45. 6.8.2 Lupin Limited Business Overview
  46. 6.8.3 Lupin Limited Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lupin Limited Hydroxychloroquine Drug Product Portfolio
  48. 6.8.5 Lupin Limited Recent Developments
  49. 6.9 Dr. Reddy’s Laboratories
  50. 6.9.1 Dr. Reddy’s Laboratories Company Information
  51. 6.9.2 Dr. Reddy’s Laboratories Business Overview
  52. 6.9.3 Dr. Reddy’s Laboratories Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dr. Reddy’s Laboratories Hydroxychloroquine Drug Product Portfolio
  54. 6.9.5 Dr. Reddy’s Laboratories Recent Developments
  55. 6.10 Amneal Pharmaceuticals
  56. 6.10.1 Amneal Pharmaceuticals Company Information
  57. 6.10.2 Amneal Pharmaceuticals Business Overview
  58. 6.10.3 Amneal Pharmaceuticals Hydroxychloroquine Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Amneal Pharmaceuticals Hydroxychloroquine Drug Product Portfolio
  60. 6.10.5 Amneal Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Hydroxychloroquine Drug Sales by Country
  2. 7.1.1 North America Hydroxychloroquine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hydroxychloroquine Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Hydroxychloroquine Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hydroxychloroquine Drug Market Size by Country
  6. 7.2.1 North America Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hydroxychloroquine Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Hydroxychloroquine Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hydroxychloroquine Drug Sales by Country
  2. 8.1.1 Europe Hydroxychloroquine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hydroxychloroquine Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Hydroxychloroquine Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hydroxychloroquine Drug Market Size by Country
  6. 8.2.1 Europe Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hydroxychloroquine Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hydroxychloroquine Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hydroxychloroquine Drug Sales by Country
  2. 9.1.1 Asia-Pacific Hydroxychloroquine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hydroxychloroquine Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hydroxychloroquine Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hydroxychloroquine Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hydroxychloroquine Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hydroxychloroquine Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hydroxychloroquine Drug Sales by Country
  2. 10.1.1 South America Hydroxychloroquine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hydroxychloroquine Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Hydroxychloroquine Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hydroxychloroquine Drug Market Size by Country
  6. 10.2.1 South America Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hydroxychloroquine Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Hydroxychloroquine Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hydroxychloroquine Drug Sales by Country
  2. 11.1.1 Middle East and Africa Hydroxychloroquine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hydroxychloroquine Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hydroxychloroquine Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hydroxychloroquine Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Hydroxychloroquine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hydroxychloroquine Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hydroxychloroquine Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hydroxychloroquine Drug Value Chain Analysis
  2. 12.1.1 Hydroxychloroquine Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hydroxychloroquine Drug Production Mode & Process
  7. 12.2 Hydroxychloroquine Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hydroxychloroquine Drug Distributors
  10. 12.2.3 Hydroxychloroquine Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst